SCHEMBL4648175

SCHEMBL4648175

CSc1ccc(-c2cc3c(c(S(=O)(=O)O)c2)OCC3)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 3/20 0.35
NRP1 O14786 4/20 0.34
LMNA P02545 2/20 0.33
ALDH1A1 P00352 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
ERN1 O75460 3/20 0.33
DYRK1A Q13627 1/20 0.33
TP53 P04637 1/20 0.32
POLB P06746 1/20 0.32
ADORA3 P0DMS8 1/20 0.32
FFAR1 O14842 1/20 0.32
MMP2 P08253 2/20 0.32
MMP9 P14780 1/20 0.32
TSHR P16473 1/20 0.31
MAPK1 P28482 1/20 0.31
PTGS1 P23219 2/20 0.31
PARP1 P09874 1/20 0.31
MMP1 P03956 1/20 0.30
MMP3 P08254 1/20 0.30
MMP13 P45452 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4646451 0.85 NRP1 (0.33) PTGS2NRP1ALDH1A1ERN1DYRK1A
SCHEMBL4649007 0.84 HSD17B1 (0.38) NRP1LMNAERN1DYRK1APARP1
SCHEMBL4648553 0.83 PARP1 (0.41) PTGS2NRP1ERN1DYRK1APARP1
SCHEMBL4645575 0.83 MAPT (0.38) PTGS2NRP1ERN1DYRK1APTGS1
SCHEMBL4647763 0.82 HSD17B1 (0.37) PTGS2NRP1LMNASMN1; SMN2ADORA3
SCHEMBL4649205 0.82 NPC1 (0.39) PTGS2ALDH1A1SMN1; SMN2ERN1DYRK1A
SCHEMBL4647459 0.80 PARP1 (0.34) PTGS2NRP1PTGS1PARP1
SCHEMBL4648461 0.80 XDH (0.44) PTGS2NRP1MMP3
SCHEMBL4648578 0.80 KIF11 (0.39) PTGS2PTGS1
SCHEMBL4648162 0.79 NRP1 (0.40) NRP1PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080255117-A1 SULFONYLTRYPTOPHANOLS BAYER SCHERING PHARMA AG (DE) 2008-10-16 US claimed
WO-2008104597-A2 SULFONYLTRYPTOPHANOLS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-09-04 WO claimed
EP-1964834-A1 Sulphonyltryptophanols Bayer Schering Pharma Aktiengesellschaft (DE) 2008-09-03 EP claimed
US-20080255117-A1 SULFONYLTRYPTOPHANOLS BAYER SCHERING PHARMA AG (DE) 2008-10-16 US disclosed
WO-2008104597-A2 SULFONYLTRYPTOPHANOLS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-09-04 WO disclosed
EP-1964834-A1 Sulphonyltryptophanols Bayer Schering Pharma Aktiengesellschaft (DE) 2008-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080255117-A1 SULFONYLTRYPTOPHANOLS FSHR, NPY1R, GNRHR PTGS2 3273/4885NRP1 2591/4885LMNA 3000/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.